Crinetics Pharmaceuticals (CRNX) has had the highest return between June 13, 2026 and September 13, 2026 by a mid-cap US stock, returning 145.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Crinetics Pharmaceuticals (CRNX) | 6/13/2026 - 9/13/2026 | 145.66% |
10X Genomics (TXG) | 6/13/2026 - 9/13/2026 | 130.71% |
CareDx (CDNA) | 6/13/2026 - 9/13/2026 | 118.33% |
Amylyx Pharmaceuticals (AMLX) | 6/13/2026 - 9/13/2026 | 113.79% |
NIQ Global Intelligence (NIQ) | 6/13/2026 - 9/13/2026 | 113.65% |
Pulse Biosciences (PLSE) | 6/13/2026 - 9/13/2026 | 112.44% |
Iovance Biotherapeutics (IOVA) | 6/13/2026 - 9/13/2026 | 108.74% |
Utz Brands (UTZ) | 6/13/2026 - 9/13/2026 | 103.57% |
PBF Energy (PBF) | 6/13/2026 - 9/13/2026 | 100.59% |
Abcellera Biologics (ABCL) | 6/13/2026 - 9/13/2026 | 98.36% |
Aveanna Healthcare (AVAH) | 6/13/2026 - 9/13/2026 | 90.79% |
AtriCure (ATRC) | 6/13/2026 - 9/13/2026 | 88.85% |
ATAI Life Sciences (ATAI) | 6/13/2026 - 9/13/2026 | 84.67% |
Ringcentral (RNG) | 6/13/2026 - 9/13/2026 | 76.72% |
Delek US Energy (DK) | 6/13/2026 - 9/13/2026 | 72.24% |
Inspire Medical Systems (INSP) | 6/13/2026 - 9/13/2026 | 71.64% |
Paymentus (PAY) | 6/13/2026 - 9/13/2026 | 71.2% |
CVR Energy (CVI) | 6/13/2026 - 9/13/2026 | 71.09% |
Calumet Specialty Products Partners (CLMT) | 6/13/2026 - 9/13/2026 | 70.62% |
Strive (ASST) | 6/13/2026 - 9/13/2026 | 69.14% |
ManpowerGroup (MAN) | 6/13/2026 - 9/13/2026 | 69.04% |
Gitlab (GTLB) | 6/13/2026 - 9/13/2026 | 66.87% |
Ionic Digital Inc Class A Common Stock (IOND) | 6/13/2026 - 9/13/2026 | 66.78% |
MBX Biosciences, Inc Common Stock (MBX) | 6/13/2026 - 9/13/2026 | 64.86% |
Wix (WIX) | 6/13/2026 - 9/13/2026 | 64.3% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.